Role of EGFR, HER2 and PIK3CA alterations in male breast cancer

被引：0
|
作者：
Rizzolo, P. [1 ]
Silvestri, V. [1 ]
Falchetti, M. [1 ]
Zanna, I. [2 ]
Palli, D. [2 ]
Ottini, L. [1 ]
机构：
[1] Univ Roma La Sapienza, Rome, Italy
[2] Canc Prevent & Res Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)70901-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
92
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [41] MUTATION ANALYSIS OF PIK3CA, HER2 AND KRAS IN A LARGE COHORT OF CHINESE PATIENTS WITH SURGICALLY RESECTED CERVICAL CANCER
    Jiang, W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 16 - 18
  • [42] PIK3CA Mutation Is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients
    Kim, Ju Won
    Lim, Ah Reum
    You, Ji Young
    Lee, Jung Hyun
    Song, Sung Eun
    Lee, Nam Kwon
    Jung, Seung Pil
    Cho, Kyu Ran
    Kim, Cheol Yong
    Park, Kyong Hwa
    CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 531 - 541
  • [43] Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab
    M Cizkova
    M-E Dujaric
    J Lehmann-Che
    V Scott
    O Tembo
    B Asselain
    J-Y Pierga
    M Marty
    P de Cremoux
    F Spyratos
    I Bieche
    British Journal of Cancer, 2013, 108 : 1807 - 1809
  • [44] Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project
    Peixoto, Ana
    Cirnes, Luis
    Carvalho, Ana Luisa
    Andrade, Maria Joao
    Brito, Maria Jose
    Borralho, Paula
    Coimbra, Nuno
    Borralho, Pedro M.
    Carneiro, Ana Sofia
    Castro, Lisandra
    Correia, Lurdes
    Dionisio, Maria Rita
    Faria, Carlos
    Figueiredo, Paulo
    Gomes, Ana
    Paixao, Joana
    Pinheiro, Manuela
    Prazeres, Hugo
    Ribeiro, Joana
    Salgueiro, Natalia
    Schmitt, Fernando C.
    Silva, Fatima
    Silvestre, Ana Rita
    Sousa, Ana Carla
    Almeida-Tavares, Joana
    Teixeira, Manuel R.
    Andre, Saudade
    Machado, Jose Carlos
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [45] Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer
    Bozhanov, Stefan S.
    Angelova, Svetla G.
    Krasteva, Maria E.
    Markov, Tsanko L.
    Christova, Svetlana L.
    Gavrilov, Ivan G.
    Georgieva, Elena I.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (11) : 1657 - 1669
  • [46] EGFR and HER2: is there a role in ovarian cancer?
    Teplinsky, Eleonora
    Muggia, Franco
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 107 - 117
  • [47] PIK3CA in colorectal cancer
    Cathomas, Gieri
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [48] Alterations in PTEN/PIK3CA/AKT pathway does not modify trastuzumab response in HER-2/NEU breast carcinomas
    Lerma, E.
    Gallardo, A.
    Peiro, G.
    Planelles, M.
    Vergara, C.
    Solis, J.
    Dominguez, N.
    Alonso, C.
    Barnadas, A.
    Prat, J.
    HISTOPATHOLOGY, 2008, 53 : 47 - 48
  • [49] Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer
    Stefan S. Bozhanov
    Svetla G. Angelova
    Maria E. Krasteva
    Tsanko L. Markov
    Svetlana L. Christova
    Ivan G. Gavrilov
    Elena I. Georgieva
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1657 - 1669
  • [50] Characterization of Lipid Alterations by Oncogenic PIK3CA Mutations Using Untargeted Lipidomics in Breast Cancer
    Jung, Jae Hun
    Yang, Da-Qing
    Song, Hongming
    Wang, Xiangyu
    Wu, Xinyan
    Kim, Kwang Pyo
    Pandey, Akhilesh
    Byeon, Seul Kee
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2023, 27 (07) : 327 - 335
12345